## MELI: MercadoLibre, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.99 indicates fundamental undervaluation. Quality metrics strong (ROE 41%). Caution: momentum weakening (-2.1% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($1817.00)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 1)

**1. China Universal Asset Management Co. Ltd. Purchases 739 Shares of MercadoLibre, Inc. $MELI**
- Source: MarketBeat | 20251214T102841 | Neutral | Relevance: 100%
- China Universal Asset Management Co. Ltd. significantly increased its stake in MercadoLibre, Inc. (NASDAQ:MELI) by 59.0%, adding 739 shares to hold a total of 1,991 shares valued at $5.204 million. Despite MercadoLibre missing its EPS expectations, analysts maintain a "Moderate Buy" rating with a consensus price target of $2,848.82. The company, which has a market cap of $102.21 billion, reported a 39.5% year-over-year revenue increase.

**2. MercadoLibre Insider Sold Shares Worth $1,713,778, According to a Recent SEC Filing**
- Source: marketscreener.com | 20251216T090850 | Bearish | Relevance: 100%
- An insider at MercadoLibre (NASDAQ: MELI) recently sold shares valued at $1,713,778, as disclosed in a recent SEC filing. The e-commerce and fintech giant continues to be active in strategic initiatives, including a deal with Agility Robotics and several financial moves. Recent analyst price targets for MercadoLibre remain high, with buy and outperform ratings.

**3. MercadoLibre (NASDAQ:MELI) Director Sells $1,713,778.30 in Stock**
- Source: MarketBeat | 20251216T010850 | Neutral | Relevance: 100%
- MercadoLibre Director Henrique Vasoncelos Dubugras sold 845 shares of MELI stock for $1,713,778.30 on December 12. This transaction comes as MercadoLibre recently reported an EPS miss of $8.32 vs. $9.88 expected, though revenue beat estimates at $7.41 billion, up 39.5% year-over-year. The stock has a "Moderate Buy" consensus from analysts with an average target price of $2,848.82.

**4. 1,236 Shares in MercadoLibre, Inc. $MELI Bought by Caxton Associates LLP**
- Source: MarketBeat | 20251215T090937 | Neutral | Relevance: 100%
- Caxton Associates LLP recently acquired 1,236 shares of MercadoLibre, Inc. (NASDAQ:MELI) valued at approximately $3.23 million in Q2, contributing to the 87.62% institutional ownership of the company. Despite missing EPS estimates, MercadoLibre saw a 39.5% year-over-year revenue increase, surpassing expectations. The stock currently trades around $2,015.89, with analysts holding a "Moderate Buy" consensus and an average price target of $2,848.82.

**5. MASTERINVEST Kapitalanlage GmbH Purchases Shares of 1,231 MercadoLibre, Inc. $MELI**
- Source: MarketBeat | 20251214T150937 | Somewhat-Bullish | Relevance: 100%
- MASTERINVEST Kapitalanlage GmbH recently acquired 1,231 shares of MercadoLibre, Inc. (NASDAQ:MELI) valued at approximately $3.217 million in the second quarter. This move comes as MercadoLibre reported mixed quarterly results, with EPS missing estimates but revenue exceeding expectations and showing significant year-over-year growth. Analysts currently rate MercadoLibre as a "Moderate Buy" with a consensus target price of $2,848.82.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | BTIG | $2750 | $2750 | 0% |
| 2025-11-24 | UBS | $2900 | $3000 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | BTIG | reit | Buy |
| 2025-11-24 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 2 ($0.60M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- JPMORGAN CHASE & CO: 7.0% (+78.3%)
- BAILLIE GIFFORD & CO: 6.5% (-5.4%)
- Morgan Stanley: 3.9% (+0.3%)
- Capital Research Glo: 3.6% (+3.4%)
- Capital World Invest: 3.4% (+1.3%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.1% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 13.4% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.99 indicates undervaluation relative to growth. Forward P/E 32.9x attractive for 49% earnings growth. Quality metrics strong (ROE 41%). Balance sheet: $2.5B free cash flow. Revenue growth strong at 29% YoY. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $99.7B |
| Beta | 1.43 |
| 52W Range | $1646.00 - $2645.22 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.99 |
| Forward P/E | 32.9 |
| Current P/E | 49.0 |
| YoY Growth | 49.1% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -1.4% to -3.5% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.5pp (needs >4.0% for momentum thesis). AM_20 at -3.7% indicates price below own 20MA trend. Underperforming sector by 7.6pp, stock-specific weakness. Below SMA200 (0.87x), long-term trend not supportive. MACD histogram bearish (-3.16), momentum weakening. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.48% (CS: 13) | Weak |
| RSI_14 | 39.7 | Neutral |
| MACD Histogram | -3.16 | Bearish |
| vs SMA20 | 0.963x | Below |
| vs SMA50 | 0.928x | Below |
| vs SMA200 | 0.866x | Below |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $1966.76
- **Stop Loss:** $1817.00 (7.6% risk)
- **Target:** $2266.28 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 8
- **Position Value:** $15,734.08
- **Portfolio %:** 15.73%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-24 (Est: $11.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.30 | $8.32 | -10.5% |
| 2025Q2 | $11.89 | $10.31 | -13.3% |
| 2025Q1 | $8.27 | $9.74 | +17.8% |
| 2024Q4 | $7.56 | $12.61 | +66.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*